Anatara Lifesciences Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	1.09	0.1	0.98	0.35	1.12	3.43
Short-Term Investments	-	-	-	0.05	0.05	-
Cash & Short-Term Investments	1.09	0.1	0.98	0.4	1.17	3.43
Cash Growth	-1.50%	-89.68%	144.80%	-65.72%	-65.90%	27.95%
Other Receivables	0.21	1.03	0.67	1	0.51	0.77
Receivables	0.21	1.03	0.67	1	0.51	0.77
Other Current Assets	0.03	0.02	0.02	0.01	0.02	0.04
Total Current Assets	1.33	1.15	1.67	1.42	1.7	4.24
Property, Plant & Equipment	-	0	0	0	0.07	0.09
Total Assets	1.33	1.15	1.67	1.42	1.77	4.33
Accounts Payable	0.17	0.17	0.25	0.44	0.15	0.2
Accrued Expenses	0.02	0.02	0.03	0.02	0.15	0.16
Short-Term Debt	-	0.41	-	-	-	-
Current Portion of Leases	-	-	-	-	0.02	0.01
Other Current Liabilities	-	0.01	0.02	0.04	0.03	0.04
Total Current Liabilities	0.19	0.61	0.3	0.49	0.36	0.4
Long-Term Leases	-	-	-	-	0.05	0.07
Pension & Post-Retirement Benefits	0.01	0.01	0	0	0	0.03
Total Liabilities	0.2	0.61	0.31	0.49	0.4	0.5
Common Stock	25.24	24.15	23.18	21.37	19.91	19.76
Retained Earnings	-24.37	-24.03	-22.09	-20.79	-18.98	-16.6
Comprehensive Income & Other	0.26	0.42	0.28	0.35	0.44	0.68
Shareholders' Equity	1.13	0.54	1.36	0.92	1.36	3.83
Total Liabilities & Equity	1.33	1.15	1.67	1.42	1.77	4.33
Total Debt	-	0.41	-	-	0.07	0.08
Net Cash (Debt)	1.09	-0.31	0.98	0.4	1.1	3.35
Net Cash Growth	-1.50%	-	144.80%	-63.67%	-67.05%	24.97%
Net Cash Per Share	0.00	-0.00	0.01	0.00	0.02	0.05
Filing Date Shares Outstanding	313.59	213.38	191.14	119.92	71.36	70.24
Total Common Shares Outstanding	313.59	213.38	191.14	119.92	71.36	70.24
Working Capital	1.14	0.54	1.37	0.92	1.34	3.84
Book Value Per Share	0.00	0.00	0.01	0.01	0.02	0.05
Tangible Book Value	1.13	0.54	1.36	0.92	1.36	3.83
Tangible Book Value Per Share	0.00	0.00	0.01	0.01	0.02	0.05